Catalyst Wire Dossier Catalyst Wire Dossier

Tirosint-SOL

Levothyroxine sodium oral solution · IBSA Institut Biochimique SA
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Tirosint-SOL, covering 2016-12-15 to 2025-10-23. Get the full timeline:

Most recent: Clinical Trial Update: Use of Tirosint®-SOL or Tablet Formulations of Levothyroxine in Pediatric Patients With Congenital Hypothyroidism (CH) [Phase 4]

See pricing